On January 30, the World Health Organization declared a global health emergency on the spread of the novel coronavirus (COVID-19) that originated in Wuhan. Healthcare experts have warned that COVID-19 could rapidly spread, if not properly contained, and many governments around the world have begun to take precautionary measures to ensure public health safety. Amid the international concern and heightened fears about the disease, what is fact and what is fiction? The Asia Society Hong Kong Center brings you regular updates on the coronavirus story in Hong Kong that has reverberations elsewhere in the world. We are pleased to present on-the-ground public health experts and internationally renowned specialists with the latest facts and evidence-based findings regarding this epidemic outbreak. In episode 8, hear from Professor David SC Hui, Chairman of the Department of Medicine & Therapeutics at the Chinese University of Hong Kong. S. Alice Mong, Executive Director of Asia Society Hong Kong Center will moderate the discussion.

Got questions? Ask them here

Professor David SC Hui graduated from the University of New South Wales in 1985. He then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia. Dr. Hui was heavily involved in the clinical management of patients with SARS during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He has contributed to the WHO treatment guidelines (including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome) and the WHO training workshop in the clinical management of influenza A(H7N9) and other severe acute respiratory infections in May 2014. Dr. Hui has published over 220 peer-reviewed journal articles and 23 book chapters since joining the Chinese University of Hong Kong in 1998. His research interests include clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the infection control in the medical ward environment in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.